Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.39K Sell
71
-8
-10% -$989 ﹤0.01% 338
2025
Q4
$9.94K Buy
+79
New +$10.3K ﹤0.01% 241
2023
Q1
Sell
-220
Closed -$32.2K 547
2022
Q4
$32.2K Buy
+220
New +$32.6K 0.01% 347

Other funds holding ZTS

Elequin Capital's ZTS Position: Q1 2026 in Review

Elequin Capital reduced its Zoetis (ZTS) stake by 10% in Q1 2026, selling an estimated $989 and leaving 71 shares worth $8.39K. The position accounts for ﹤0.01% of the portfolio, ranked #338.

Elequin Capital first reported a position in ZTS in Q4 2022 and has held it in 3 quarters since. The position peaked at $32.2K in Q4 2022. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Elequin Capital held 71 shares of Zoetis worth $8.39K as of Q1 2026.
  • Elequin Capital sold 8 Zoetis shares in Q1 2026, an estimated $989.
  • Zoetis made up ﹤0.01% of Elequin Capital's portfolio in Q1 2026, its #338 holding.
  • Elequin Capital first reported a position in Zoetis in Q4 2022 and has held it in 3 quarters since.
  • Elequin Capital's Zoetis position peaked at $32.2K in Q4 2022.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.